Ozempic Lawsuit: August 2026 Blindness and Gastroparesis Claims

As of August 2026, litigation against the manufacturer of Ozempic continues to develop, with plaintiffs alleging that the drug caused serious adverse effects including blindness and gastroparesis. The source identifies these as active claims within the broader Ozempic litigation landscape but does not specify verdicts, settlements, or trial outcomes in the provided title and description.

This is a curated brief from the PlaintiffWire news desk. Read the original report at Drugwatch.com.